Phenylboronic acid in targeted cancer therapy and diagnosis
Theranostics · 03.03.2025 · 15 (9) · 3733-3749
DOI: 10.7150/thno.104558 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Theranostics, erschienen am 03.03.2025. Verfasst von Mila Radan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chemistry and Technology, University of Split, Ruđera Boškovića 35, 21000 Split, Croatia. Hauptthemen laut MEDLINE: Boronic Acids, Neoplasms, Antineoplastic Agents, Drug Delivery Systems. Die Arbeit wurde bisher 22-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Chemistry and Technology, University of Split, Ruđera Boškovića 35, 21000 Split, Croatia.
Zitieren
APA
Radan, M., Carev, I., Miloš, M., & Tranfić Bakić, M. (2025). Phenylboronic acid in targeted cancer therapy and diagnosis. Theranostics, 15(9), 3733-3749. https://doi.org/10.7150/thno.104558
Vancouver
Radan M, Carev I, Miloš M, Tranfić Bakić M. Phenylboronic acid in targeted cancer therapy and diagnosis. Theranostics. 2025;15(9):3733-3749. doi:10.7150/thno.104558
BibTeX
@article{Radan2025,
author = {Radan, Mila and Carev, Ivana and Miloš, Mladen and Tranfić Bakić, Marina},
title = {Phenylboronic acid in targeted cancer therapy and diagnosis},
journal = {Theranostics},
year = {2025},
volume = {15},
number = {9},
pages = {3733--3749},
doi = {10.7150/thno.104558}
}
EUVIMED